Related Experiment Video
Updated: Jun 19, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Body size and atrial fibrillation in Japanese outpatients
Shinya Suzuki1, Takeshi Yamashita, Takayuki Ohtsuka
1Department of Clinical Epidemiology&Systems, Graduate School of Medicine, The University of Tokyo, Japan. sinsuz-tky@umin.ac.jp
Background:
Although recent studies have suggested that height and body mass index (BMI) independently affect the prevalence of atrial fibrillation (AF), their combined effects have not been fully examined in Japanese patients.
Methods And Results:
Patients without organic cardiac diseases, hypertension and diabetes mellitus were screened from a prospective, single hospital-based cohort of the Shinken Database 2004-2007 (n=4,719). Both height and BMI significantly increased the crude rate of AF prevalence and the effects were significant even after adjustment by age, sex and left atrial dimension. The relative risks (RRs) for AF in the height and BMI categories were 2.07 (95% confidence interval [CI] 1.70-2.52) and 1.78 (95%CI 1.46-2.17), respectively, in the highest tertile compared with the lowest tertile. The RRs in the highest combined tertile was high to 2.98 (95%CI 2.07-4.28) compared with the lowest combined tertile, an unignorable figure for AF prevalence in the future.
Conclusions:
Height and BMI synergistically affected the prevalence of AF in Japanese patients. With respect to the recent increase in body size of the Japanese population, the present study predicts that there will be more occurrences of AF than previously predicted. (Circ J 2010; 74: 66 - 70).
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Rheumatic Heart Disease III: Medical Management
Dysrhythmias VI: Management of Dysrhythmias
Mitral Regurgitation III: Medical Management
Aortic Regurgitation III: Medical Management
Coronary Artery Disease IV: Preventive Measures

